Legal Opinion
In Re Buspirone Patent Litigation
District Court, S.D. New York
Decided February 14, 2002No. MDL Docket 1410PublishedCited by 8 opinions
1Opinion of the Court
Opinion and Order No. 18
KOELTL, District Judge.
(Motion For Summary Judgment on Patent Infringement Claims)
On August 15, 2001, the Judicial Panel on Multidistrict Litigation consolidated for pre-trial purposes before this Court four patent actions, which had been consolidated under MDL-1410, and twenty-two antitrust actions, which had been consolidated under MDL-1413. All of these cases involve disputes among the various parties over the propriety of the manufacture, use, sale or allegedly anticompetitive conduct related to the use and sale of the drug buspirone 1 to treat anxiety. Since that…
2Cases cited39 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- United States v. Diebold, Inc.Supreme Court of the United States · 1962
34 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- In Re Ciprofloxacin Hydrochloride Antitrust LitigationDistrict Court, E.D. New York · 2003
- In re Buspirone Patent LitigationDistrict Court, S.D. New York · 2002
- Netscape Communications Corp. v. VALUECLICK, INC.District Court, E.D. Virginia · 2010
- In Re Terazosin Hydrochloride Antitrust LitigationDistrict Court, S.D. Florida · 2005
- In re Buspirone Antitrust LitigationDistrict Court, S.D. New York · 2002
3 more not listed; retrieve them via the Exa API.